Alta Partners reports 7.7% stake in BioRestorative
Alta Partners LLC has filed a Schedule 13G reporting a significant passive ownership position in BioRestorative Therapies, Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alta Partners LLC has filed a Schedule 13G reporting a significant passive ownership position in BioRestorative Therapies, Inc. common stock. Alta Partners beneficially owns 1,787,163 shares, representing 7.7% of the company’s outstanding common stock.
Alta Partners reports sole voting and dispositive power over all 1,787,163 shares and no shared power. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of BioRestorative Therapies.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Alta Partners LLC report in BioRestorative Therapies (BRTX)?
Is Alta Partners’ BioRestorative (BRTX) position reported as passive or active?
Why did Alta Partners LLC have to file a Schedule 13G for BRTX?
Does Alta Partners’ 13G filing mention any warrants in BioRestorative (BRTX)?
Who signed the Alta Partners ownership report for BioRestorative (BRTX)?
AI-generated analysis. How Rhea-AI works. Not financial advice.